Skip to main content
OpenTrials

Clinical trial condition

Relapsed/Refractory Acute Myeloid Leukemia

Explore clinical trials studying Relapsed/Refractory Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

11 public trials 5 recruiting studies

Relapsed/Refractory Acute Myeloid Leukemia trial results

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations
  • City of Hope Duarte, California, United States
  • UCLA Ronald Reagan Medical Center Los Angeles, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Yale Cancer Center, Smilow Cancer Hospital at Yale New Haven New Haven, Connecticut, United States
View all 18 locations
Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations
  • City of Hope - Duarte Duarte, California, United States
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • Medical Oncology Hematology Consultants Newark, Delaware, United States
  • Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
Enrolling by Invitation

Long-Term Follow-up Study

NCT05332054

Conditions
B Cell Lymphoma, B-cell Non-Hodgkin's Lymphoma, Blood Protein Disorders, +29 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • University of California Irvine Irvine, California, United States
View all 31 locations
Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Anemia, +39 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UCSF Precision Cancer Medicine Building San Francisco, California, United States
  • Christiana Care Health Services, Christiana Hospital Newark, Delaware, United States
  • Florida Cancer Specialists Lake Mary, Florida, United States
View all 23 locations